Filing Details
- Accession Number:
- 0001415889-15-003934
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-30 16:40:26
- Reporting Period:
- 2015-11-09
- Filing Date:
- 2015-11-30
- Accepted Time:
- 2015-11-30 16:40:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1591165 | Medovex Corp. | MDVX | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1033742 | Steve Gorlin | 3279 Hardee Avenue Atlanta GA 30341 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-11-24 | 40,000 | $1.45 | 369,462 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Convertible Note | Acquisiton | 2015-11-09 | 1 | $2,000,000.00 | 0 | $0.00 |
Common Stock | Warrants | Acquisiton | 2015-11-09 | 500,000 | $1,100,000.00 | 500,000 | $2.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1 | 2015-11-09 | 2015-11-09 | No | 4 | P | Direct |
0 | 2015-11-09 | 2018-11-09 | No | 4 | P | Direct |
Footnotes
- Includes 125,000 shares held by Mr. Gorlin's spouse, Deborah Gorlin. Mr. Gorlin disclaims beneficial ownership of Deborah Gorlin's shares.
- On November 9, 2015, the Company issued a convertible promissory note (the "Note") to Steve Gorlin. The Note's principal amount is $2,000,000 and bears interest at a rate of 5.5% annually and will mature two years from the issuance date. The Note is convertible such number of shares of common stock equal to the quotient of (a) the outstanding principal amount and accrued interest of the Note as of date of conversion, divided by (b) $2.00, subject to adjustment.
- In addition to the Note, the Reporting Person received a warrant to purchase 500,000 shares of common stock, exercisable at $2.20 per share for three years.